Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2005
06/28/2005US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity
06/28/2005US6911443 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
06/28/2005CA2350538C Pyrazolopyrimidinone derivatives for the treatment of impotence
06/28/2005CA2331468C Pyrazolo[1,5-a]pyrimidine derivatives
06/23/2005WO2005057215A1 Membrane-based lateral flow assay devices that utilize phosphorescent detection
06/23/2005WO2005056560A1 Process for the preparation of tubulin inhibitors
06/23/2005WO2005056559A1 Pyrazolopyrimidines
06/23/2005WO2005056558A1 Pyrazolopyrimidines as fungicidal active ingredients
06/23/2005WO2005056557A1 7-amino-5-halopyrazolopyrimidines with a fungicidal action
06/23/2005WO2005056556A1 Pyrazolopyrimidines
06/23/2005WO2005056555A1 Pyrazolopyrimidines
06/23/2005WO2005056554A2 Azepinoindole derivatives as pharmaceutical agents
06/23/2005WO2005056553A1 A new process for preparation of imipenem
06/23/2005WO2005056547A2 Quinoxalines useful as inhibitors of protein kinases
06/23/2005WO2005056528A1 Carboxamide derivatives
06/23/2005WO2005056523A2 Methodology for preparing combinatorial libraries based upon a bicyclic scaffold
06/23/2005WO2005056514A2 Process for preparation of substituted amino alcohols
06/23/2005WO2005056066A2 Ph dependent medicinal compositions
06/23/2005WO2005055943A2 Vinorelbine derivatives
06/23/2005WO2005055939A2 Vinca derivatives
06/23/2005WO2005033930A3 Process for upgrading naphtha
06/23/2005WO2004041258A8 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
06/23/2005US20050137399 A lithium-free reaction to produce a substituted/unsubstituted 4-amino-3-benzimidazol-2-yl-quinolin-2-one compound by reacting a 2-aminobenzonitrile with a 2-alkyloxycarbonylmethyl-benzimidazole in a solvent in the presence of a sodium or potassium salt of a base; excellent yields
06/23/2005US20050137394 Porphines-platinum metal complex compounds for organic electroluminescent device and organic electroluminescent device using them
06/23/2005US20050137245 Novel fused pyrrolocarbazoles
06/23/2005US20050137224 2-Cyanopyrrolidinecarboxamide compound
06/23/2005US20050137216 Heterocyclic sodium/proton exchange inhibitors and method
06/23/2005US20050137215 Antiarthritic and antiinflammatory agents; analgesics; the proline derivatives do not displace gabapentin from alpha-2-delta receptors
06/23/2005US20050137213 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
06/23/2005US20050137202 Heterocyclic compounds as antiinflammatory agents and cyclooxygenase inhibitors
06/23/2005US20050137201 Compositions useful as inhibitors of protein kinases
06/23/2005US20050137196 Medical devices employing triazine compounds and compositions thereof
06/23/2005US20050137191 Nitrate esters and their use for mitigating cellular damage
06/23/2005US20050137180 Porphrins or azaporprins for photosensitizing therapy or photodetection with azaporprins for cardiovascular disorders and coordination with metals
06/23/2005US20050137169 Vinca derivatives
06/23/2005US20050136343 Colored curable composition, color filter and manufacturing method thereof
06/23/2005US20050132927 Phthalocyanine compound, ink, inkjet recording method, and image forming method
06/23/2005CA2549548A1 Carboxamide derivatives
06/23/2005CA2548516A1 Pyrazolopyrimidines
06/23/2005CA2548172A1 Quinoxalines useful as inhibitors of protein kinases
06/23/2005CA2546907A1 Process for preparation of substituted amino alcohols
06/23/2005CA2546899A1 Process for the preparation of tubulin inhibitors
06/22/2005EP1544201A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
06/22/2005EP1544200A1 1,2,4 -TRIAZOLO 1,5-c PYRIMIDINE DERIVATIVE
06/22/2005EP1544199A1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor
06/22/2005EP1543009A1 Pyrrolotriazine kinase inhibitors
06/22/2005EP1543008A1 Imidazopyrazines as cyclin dependent kinase inhibitors
06/22/2005EP1543007A1 Novel zwitterionic fluorescent dyes for labeling in proteomic and other biological analyses
06/22/2005EP1542999A1 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
06/22/2005EP1542995A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors
06/22/2005EP1542994A1 Novel triazole and oxazole compounds as transforming growth factor (tgf) inhibitor
06/22/2005EP1542993A1 Piperazine derivatives and methods of use
06/22/2005EP1542990A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors
06/22/2005EP1542693A1 Novel imidazopyrazines as cyclin dependent kinase inhibitors
06/22/2005EP1542685A1 Triazole derivatives as transforming growth factor (tgf) inhibitors
06/22/2005EP1381611B1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
06/22/2005EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors
06/22/2005EP1360187B1 3,7-diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias
06/22/2005EP1268466B1 Decahydro-isoquinolines
06/22/2005EP1233964B1 New use and novel n-azabicyclo-amide derivatives
06/22/2005CN1630658A Variolin derivatives as anti-cancer agents
06/22/2005CN1630651A Novel gamma secretase inhibitors
06/22/2005CN1629163A Pyrazolopyrimidine compounds for prevention and cure of impotence and frigidity
06/22/2005CN1207298C Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents
06/22/2005CN1207297C Crystalline therapeutic agent
06/22/2005CN1207296C Farnesyl transferase inhibiting 1, 2-annelated quinoline enantiomer
06/22/2005CN1207295C Method for preparing pyrazo-(4, 3-d) pyrimidine-7-ketone and its intermediate
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors
06/21/2005US6908926 Substituted imidazoles, their preparation and use
06/21/2005US6908916 C-5 modified indazolylpyrrolotriazines
06/21/2005CA2250372C 6-phenylpyridyl-2-amine derivatives
06/21/2005CA2108068C Carbamates of rapamycin
06/16/2005WO2005054247A1 Diazaindole-dicarbonyl-piperazinyl antiviral agents
06/16/2005WO2005054246A2 Amine derivatives having a tyrosine-kinase-inhibiting effect
06/16/2005WO2005054245A2 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
06/16/2005WO2005054242A1 Muscarinic agents as therapeutic compounds
06/16/2005WO2005054239A1 2-aminopyrimidine derivatives
06/16/2005WO2005054232A1 1-acetic acid-indole, -indazole and-benzimidazole derivatives usful for the treatment of respiratory disorders
06/16/2005WO2005053842A1 Pentasil-structuer zeolithic material the production and use thereof
06/16/2005WO2005053735A1 Method of removing transition metals, especially from metathesis reaction products
06/16/2005WO2005053695A1 Preventive or therapeutic agent for multiple sclerosis
06/16/2005WO2005037928A3 Compounds for dual photodiagnosis and therapy
06/16/2005WO2005032481A3 Quinazoline derivatives as medicaments
06/16/2005WO2005025293A3 Fused ring heterocycles as potassium channel modulators
06/16/2005WO2005018532A3 Purine receptor binding compounds
06/16/2005WO2005013892A3 Hydrolytically-resistant boron-containing therapeutics and methods of use
06/16/2005WO2005007658A3 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
06/16/2005WO2005005430A3 Process for the preparation of furopyrroles
06/16/2005WO2004084817A3 Siderophore conjugates of photoactive dyes for photodynamic therapy
06/16/2005US20050131236 Central nervous ystem disorders; neurodegenerative disorders; muscle contraction; endocrine diseases
06/16/2005US20050131231 Process for preparing cyclic N-substituted alpha-imino carboxlic acids
06/16/2005US20050131230 Method and associated compounds for forming nanotubes
06/16/2005US20050131227 Synthesis of temozolomide and analogs
06/16/2005US20050131220 Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides
06/16/2005US20050131177 1-Alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
06/16/2005US20050131051 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon
06/16/2005US20050131004 8-[2-(6,6-Dimethyl-bicyclo[3.1.1]hept-2-yl)-ethyl]-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one and derivatives; treating metabolic, gastrointestinal, urogenital, renal, cardiovascular, opthalmological, respiratory, and immunological disorders and viral infections; especially diarrhea and visceral pain
06/16/2005US20050130994 Antiproliferative agents; skin, prostate glands, kidneys, central nervous system
06/16/2005US20050130992 2-phenyl-4-trifluoromethyl-imidazo[1,5-a]pyrimidine-8-carbonitrile; treat or prevent acute or chronic neurological disorder
1 ... 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 ... 573